AU2003232176A8 - Protein c variants with altered properties - Google Patents

Protein c variants with altered properties

Info

Publication number
AU2003232176A8
AU2003232176A8 AU2003232176A AU2003232176A AU2003232176A8 AU 2003232176 A8 AU2003232176 A8 AU 2003232176A8 AU 2003232176 A AU2003232176 A AU 2003232176A AU 2003232176 A AU2003232176 A AU 2003232176A AU 2003232176 A8 AU2003232176 A8 AU 2003232176A8
Authority
AU
Australia
Prior art keywords
variants
protein
altered properties
altered
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003232176A
Other versions
AU2003232176A1 (en
Inventor
Bobby Soni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen ApS
Maxygen Holdings Ltd
Original Assignee
Maxygen ApS
Maxygen Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen ApS, Maxygen Holdings Ltd filed Critical Maxygen ApS
Publication of AU2003232176A1 publication Critical patent/AU2003232176A1/en
Publication of AU2003232176A8 publication Critical patent/AU2003232176A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
AU2003232176A 2002-06-14 2003-06-13 Protein c variants with altered properties Abandoned AU2003232176A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38889202P 2002-06-14 2002-06-14
US60/388,892 2002-06-14
PCT/DK2003/000392 WO2003106666A2 (en) 2002-06-14 2003-06-13 Protein c variants with altered properties

Publications (2)

Publication Number Publication Date
AU2003232176A1 AU2003232176A1 (en) 2003-12-31
AU2003232176A8 true AU2003232176A8 (en) 2003-12-31

Family

ID=29736559

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232176A Abandoned AU2003232176A1 (en) 2002-06-14 2003-06-13 Protein c variants with altered properties

Country Status (2)

Country Link
AU (1) AU2003232176A1 (en)
WO (1) WO2003106666A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113385A1 (en) * 2003-06-20 2004-12-29 Maxygen Holdings Ltd. Protein c propeptide variants
WO2006044294A2 (en) * 2004-10-14 2006-04-27 Eli Lilly And Company Human protein c analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
SE9701228D0 (en) * 1997-04-03 1997-04-03 Bjoern Dahlbaeck Recombinant protein C and protein S variants
AU1038802A (en) * 2000-10-18 2002-04-29 Maxygen Aps Protein c or activated protein c-like molecules

Also Published As

Publication number Publication date
WO2003106666A3 (en) 2007-11-15
WO2003106666A2 (en) 2003-12-24
AU2003232176A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2003254001A8 (en) Novel htnfsf13b protein variants
AU2003232176A8 (en) Protein c variants with altered properties
GB0201808D0 (en) Protein
GB0208089D0 (en) Protein
PL376318A1 (en) Protein modification
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0204735D0 (en) Protein
GB0202748D0 (en) Protein
GB0207141D0 (en) Modified protein
GB0216601D0 (en) Modified protein
GB0203165D0 (en) Protein
GB0210141D0 (en) Protein
GB0202668D0 (en) Protein
GB0203160D0 (en) Protein
GB0202669D0 (en) Protein
GB0207471D0 (en) Protein
GB0203040D0 (en) Protein
GB0203155D0 (en) Protein
GB0203161D0 (en) Protein
GB0203158D0 (en) Protein
GB0208278D0 (en) Protein
GB0203157D0 (en) Protein
GB0203156D0 (en) Protein
GB0203164D0 (en) Protein
GB0203167D0 (en) Protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 8, PAGE(S) 2112 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME MAXYGEN APS, APPLICATION NO. 2003232176, UNDER INID (71) CORRECT THE NAME TO READ MAXYGEN APS; MAXYGEN HOLDINGS LTD.